Biological Pathway Taxonomy

Last uploaded: March 30, 2022
Preferred Name

Atopic Dermatitis

Synonyms

PMID: 19494826

PathwayType: signaling

Organ: skin

CellType: T-cell

CellType: corneocyte

PMID: 20081870

Description: Atopic dermatitis (AD) is a chronic skin disorder that involves scaly and itchy rashes. Pathway is built manually using published studies.

Notes: Headnote: Atopic dermatitis (AD) is a chronic skin disorder characterized by scaly and itchy rashes. It typically involves a skin reaction similar to an allergy, which leads to an ongoing swelling and redness. AD is associated with the impaired skin barrier function and IgE-mediated sensitization to food and environmental allergens. Signaling description: Skin penetration barrier is located in the lower part of the stratum corneum (SC). Structural integrity of the SC is maintained by the presence of modified desmosomes known as corneodesmosomes, which bind the corneocytes together. Corneodesmosomes are formed by members of the cadherin family of extracellular transmembrane glycoproteins including desmoglein (DSG) and desmocollin (DSC). Within the corneocytes, DSG and DSC are linked to keratin filaments through corneodesmosomal plaque proteins including plakoglobin (JUP), desmoplakin (DSP), and plakophilin (PKP). DSG and DSC migrate from the corneocyte envelope into the lipid lamellae sandwiched between the corneocytes and bind to the corneodesmosomal plaque proteins on adjacent cells. Also, filaggrin (FLG) is an epithelial cell protein, which is extensively deaminated through the actions of the peptidyl deiminase (PADI1) enzyme. It is subsequently degraded into small peptides and then into free amino acids, which are then catabolized into the components of natural moisturizing factor (NMF) including lactic acid, sodium pyrrolidone carboxylic acid, urocanate, and urea. The NMF is essential for the retention of water within the corneocytes and results in their optimal hydration and swelling. The human kallikrein (KLK)-related peptidases such as SC chymotryptic enzyme (KLK7) and SC tryptic enzyme (KLK5) are key proteases involved in desquamation. Their increased expression can lead to impaired epidermal barrier function in AD. KLK7, with chymotrypsin-like activity, has been shown to hydrolyze corneodesmosin (CDSN) and desmocollin 1 (DSC1), whereas KLK5 can cleave desmoglein 1 (DSG1) with its trypsin-like activity. Enzymatically active KLK14, also exhibiting trypsin-like activity is present in the SC, where it cleaves DSG1. In addition, SPINK5 is a potent inhibitor of both KLK5 and KLK7, and thus, is critical for epidermal barrier function. As the pH becomes more acidic, the inhibitory potential of SPINK5 is reduced. The inhibition by SPINK5 in the superficial layers of the SC is sufficiently reduced to support localized desquamation. Outcome effects: Following contact with an antigen e.g. Staphylococcus aureus, during the elicitation phase cutaneous professional antigen presenting cells migrate to regional lymph nodes, where they present the processed peptides to naive T-cells. In the presence of IL4, naive T-lymphocytes differentiate toward the Th2 phenotype and induce class switching of B- lymphocytes to IgE production. Circulating IgE binds to high affinity IgE receptors on tissue resident mast cells. A second exposure to the antigen causes cell reactivation, mast cell degranulation, and release of inflammatory molecules such as histamine, IL8, and IL13 which causes a Th2-lymphocyte influx into the skin. However, with the infiltration of eosinophils and macrophages in chronic AD, there is a rise in IL12 expression and a switch to Th1 cellular responses. Acute skin lesions of patients with AD have increased amounts of cells positive for IL4, IL5, and IL13 mRNA compared to normal or uninvolved skin. In contrast, there are few IFNG or IL12 mRNA expressing cells in acute skin lesions of patients with AD. Lastly, recent evidence suggests a possible role for IL33/IL1RL1 pathway in epithelial integrity, allergic immune responses, inflammation, autoimmunity, and fibrosis. IL33-dependent activation of IL1RL1 signaling leads to the activation of MAPK and NF-kB signaling which ultimately have roles in the pathogenesis of AD. The mature form of IL33 is released into the cytoplasm and thus stimulates T-cells, mast cells, or keratino

PMID: 22499037

CellType: mast cell

NodeType: Pathway

Link: https://mammal-profservices.pathwaystudio.com/app/sd?urn=urn:agi-pathway:uuid-7bbbbfa5-94a0-40de-807f-4d29a0f39a26

Tissue: epidermis

Pathway_Author: V. Sobolev ORCID:0000-0003-4779-156X

Organ_System: integumentary system

PMID: 21249468

PMID: 22561834

Source: Diseases

ID

urn:agi-pathway:uuid-7bbbbfa5-94a0-40de-807f-4d29a0f39a26

database_cross_reference

PS:PathwayType

PS:Description

PS:Tissue

PS:Pathway_Author

PS:Link

PS:CellType

PS:Organ_System

PS:PMID

PS:NodeType

PS:Notes

PS:Organ

PS:Source

has_exact_synonym

PMID: 19494826

PathwayType: signaling

Organ: skin

CellType: T-cell

CellType: corneocyte

PMID: 20081870

Description: Atopic dermatitis (AD) is a chronic skin disorder that involves scaly and itchy rashes. Pathway is built manually using published studies.

Notes: Headnote: Atopic dermatitis (AD) is a chronic skin disorder characterized by scaly and itchy rashes. It typically involves a skin reaction similar to an allergy, which leads to an ongoing swelling and redness. AD is associated with the impaired skin barrier function and IgE-mediated sensitization to food and environmental allergens. Signaling description: Skin penetration barrier is located in the lower part of the stratum corneum (SC). Structural integrity of the SC is maintained by the presence of modified desmosomes known as corneodesmosomes, which bind the corneocytes together. Corneodesmosomes are formed by members of the cadherin family of extracellular transmembrane glycoproteins including desmoglein (DSG) and desmocollin (DSC). Within the corneocytes, DSG and DSC are linked to keratin filaments through corneodesmosomal plaque proteins including plakoglobin (JUP), desmoplakin (DSP), and plakophilin (PKP). DSG and DSC migrate from the corneocyte envelope into the lipid lamellae sandwiched between the corneocytes and bind to the corneodesmosomal plaque proteins on adjacent cells. Also, filaggrin (FLG) is an epithelial cell protein, which is extensively deaminated through the actions of the peptidyl deiminase (PADI1) enzyme. It is subsequently degraded into small peptides and then into free amino acids, which are then catabolized into the components of natural moisturizing factor (NMF) including lactic acid, sodium pyrrolidone carboxylic acid, urocanate, and urea. The NMF is essential for the retention of water within the corneocytes and results in their optimal hydration and swelling. The human kallikrein (KLK)-related peptidases such as SC chymotryptic enzyme (KLK7) and SC tryptic enzyme (KLK5) are key proteases involved in desquamation. Their increased expression can lead to impaired epidermal barrier function in AD. KLK7, with chymotrypsin-like activity, has been shown to hydrolyze corneodesmosin (CDSN) and desmocollin 1 (DSC1), whereas KLK5 can cleave desmoglein 1 (DSG1) with its trypsin-like activity. Enzymatically active KLK14, also exhibiting trypsin-like activity is present in the SC, where it cleaves DSG1. In addition, SPINK5 is a potent inhibitor of both KLK5 and KLK7, and thus, is critical for epidermal barrier function. As the pH becomes more acidic, the inhibitory potential of SPINK5 is reduced. The inhibition by SPINK5 in the superficial layers of the SC is sufficiently reduced to support localized desquamation. Outcome effects: Following contact with an antigen e.g. Staphylococcus aureus, during the elicitation phase cutaneous professional antigen presenting cells migrate to regional lymph nodes, where they present the processed peptides to naive T-cells. In the presence of IL4, naive T-lymphocytes differentiate toward the Th2 phenotype and induce class switching of B- lymphocytes to IgE production. Circulating IgE binds to high affinity IgE receptors on tissue resident mast cells. A second exposure to the antigen causes cell reactivation, mast cell degranulation, and release of inflammatory molecules such as histamine, IL8, and IL13 which causes a Th2-lymphocyte influx into the skin. However, with the infiltration of eosinophils and macrophages in chronic AD, there is a rise in IL12 expression and a switch to Th1 cellular responses. Acute skin lesions of patients with AD have increased amounts of cells positive for IL4, IL5, and IL13 mRNA compared to normal or uninvolved skin. In contrast, there are few IFNG or IL12 mRNA expressing cells in acute skin lesions of patients with AD. Lastly, recent evidence suggests a possible role for IL33/IL1RL1 pathway in epithelial integrity, allergic immune responses, inflammation, autoimmunity, and fibrosis. IL33-dependent activation of IL1RL1 signaling leads to the activation of MAPK and NF-kB signaling which ultimately have roles in the pathogenesis of AD. The mature form of IL33 is released into the cytoplasm and thus stimulates T-cells, mast cells, or keratino

PMID: 22499037

CellType: mast cell

NodeType: Pathway

Link: https://mammal-profservices.pathwaystudio.com/app/sd?urn=urn:agi-pathway:uuid-7bbbbfa5-94a0-40de-807f-4d29a0f39a26

Tissue: epidermis

Pathway_Author: V. Sobolev ORCID:0000-0003-4779-156X

Organ_System: integumentary system

PMID: 21249468

PMID: 22561834

Source: Diseases

id

urn:agi-pathway:uuid-7bbbbfa5-94a0-40de-807f-4d29a0f39a26

label

Atopic Dermatitis

notation

uuid-7bbbbfa5-94a0-40de-807f-4d29a0f39a26

prefLabel

Atopic Dermatitis

treeView

urn:agi-folder:a

urn:agi-folder:atopic_dermatitis

urn:agi-folder:epidermis

urn:agi-folder:integumentary_system

subClassOf

urn:agi-folder:a

urn:agi-folder:atopic_dermatitis

urn:agi-folder:epidermis

urn:agi-folder:integumentary_system

Delete Subject Author Type Created
No notes to display
Create mapping

Delete Mapping To Ontology Source
http://purl.obolibrary.org/obo/SCDO_0000088 SCDO LOOM
http://purl.bioontology.org/ontology/SNOMEDCT/24079001 SNOMEDCT LOOM
http://purl.obolibrary.org/obo/DERMO_0000122 DERMO LOOM
http://purl.bioontology.org/ontology/MEDLINEPLUS/C0011615 MEDLINEPLUS LOOM
http://www.owl-ontologies.com/unnamed.owl#RID15657 DERMLEX LOOM
http://purl.bioontology.org/ontology/ICD10/L20 ICD10 LOOM
http://www.semanticweb.org/ontologies/2012/11/abnormalities.owl#phenodb:2064 IFAR LOOM
http://purl.bioontology.org/ontology/OMIM/MTHU004090 OMIM LOOM
http://purl.bioontology.org/ontology/RCD/M111. RCD LOOM
http://purl.bioontology.org/ontology/ICD10CM/L20 ICD10CM LOOM
http://www.phoc.org.cn/pmo/class/PMO_00008391 PMAPP-PMO LOOM
http://purl.obolibrary.org/obo/DOID_3310 DTO LOOM
http://purl.obolibrary.org/obo/DOID_3310 DOID LOOM
http://purl.obolibrary.org/obo/DOID_3310 BAO LOOM
http://purl.obolibrary.org/obo/DOID_3310 HHEAR LOOM
http://purl.obolibrary.org/obo/DOID_3310 NIFSTD LOOM
http://purl.obolibrary.org/obo/DOID_3310 FNS-H LOOM
http://purl.bioontology.org/ontology/MEDDRA/10003639 MEDDRA LOOM
http://purl.obolibrary.org/obo/NCIT_C3001 VRD LOOM
http://purl.obolibrary.org/obo/HP_0001047 HP LOOM
http://purl.obolibrary.org/obo/HP_0001047 UPHENO LOOM
http://localhost/plosthes.2017-1#3691 PLOSTHES LOOM
http://purl.jp/bio/4/id/200906043758639271 IOBC LOOM
http://www.owl-ontologies.com/NPOntology.owl#DOID_3310 NATPRO LOOM
http://purl.bioontology.org/ontology/ICPC2P/S87003 ICPC2P LOOM
http://sbmi.uth.tmc.edu/ontology/ochv#C0011615 OCHV LOOM
http://purl.bioontology.org/ontology/CSP/2716-6917 CRISP LOOM